Number | Percent | 95% CI (%) | |
---|---|---|---|
First adequate screening specimena | 4034 | ||
> 100,000 CFU/mL, symptomatic | 47 | 1.2 | 0.9–1.5 |
> 100,000 CFU/mL, asymptomatic | 183 | 4.5 | 3.9–5.2 |
1000- < 100,000 CFU/mL, symptomatic | 130 | 3.2 | 2.7–3.8 |
1000- < 100,000 CFU/mL, asymptomatic | 469 | 11.6 | 10.7–12.6 |
No Growth (Normal) | 3205 | 79.5 | 78.2–80.7 |
First Test of cure specimen | 276 | ||
> 100,000 CFU/mL, symptomatic | 5 | 1.8 | 0.8–4.3 |
> 100,000 CFU/mL, asymptomatic | 36 | 13.0 | 9.6–17.7 |
1000- < 100,000 CFU/mL, symptomatic | 15 | 5.4 | 3.3–8.9 |
1000- < 100,000 CFU/mL, asymptomatic | 34 | 12.3 | 9.0–16.9 |
No Growth (Normal) | 186 | 67.4 | 62.1–73.2 |
Second Test of cure specimen | 42 | ||
> 100,000 CFU/mL, symptomatic | 2 | 4.8 | 1.2–18.4 |
> 100,000 CFU/mL, asymptomatic | 8 | 19.0 | 10.2–35.5 |
1000- < 100,000 CFU/mL, symptomatic | 1 | 2.4 | 0.3–16.5 |
1000- < 100,000 CFU/mL, asymptomatic | 6 | 14.3 | 6.8–30.0 |
No Growth (Normal) | 25 | 59.5 | 46.4–76.4 |